ScienceDex / Researcher record
Nicholas H. Oberlies
- Washington State University (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,613,928 | 3 | #7,690 |
| 2025 | $1,258,627 | 2 | #12,843 |
| 2026 | $4,236,367 | 4 | #3,751 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected3 records
- FY20252 records
- FY20264 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6201729Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-0354-8464Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award records by amount
NIH award records listing Nicholas H. Oberlies as a PI. Multi-PI records show the full award amount for context.
- 5R44CA285062-02R44Co-investigatorAssigning mode of action to phenotypically discovered anticancer leads.$1Maward amount
- 5U54AT008909-10U54Contact PINatural Product-Drug Interaction Research: The Roadmap to Best Practices$470.7Kaward amount
- 5P01CA125066-15P01Co-investigatorDiscovery of Anticancer Agents of Diverse Natural Origin$143.3Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Nicholas H. Oberlies as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAttagene, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7690
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 3 institutions
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #3751
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Nicholas H. Oberlies.